132 related articles for article (PubMed ID: 4066206)
21. Plasminogen activators and their inhibitor in osteosarcomas and other bone tumors.
Häkel C; Ueda Y; Tsuchya H; Herrera A; Blasius S; Roessner A
Zentralbl Pathol; 1994 Nov; 140(4-5):363-9. PubMed ID: 7826985
[TBL] [Abstract][Full Text] [Related]
22. Primary tumor and metastasis in ovarian cancer differ in their content of urokinase-type plasminogen activator, its receptor, and inhibitors types 1 and 2.
Schmalfeldt B; Kuhn W; Reuning U; Pache L; Dettmar P; Schmitt M; Jänicke F; Höfler H; Graeff H
Cancer Res; 1995 Sep; 55(18):3958-63. PubMed ID: 7664262
[TBL] [Abstract][Full Text] [Related]
23. Relationship between multiple forms of plasminogen activator in human breast tumors and plasma and the presence of metastases in lymph nodes.
Colombi M; Barlati S; Magdelenat H; Fiszer-Szafarz B
Cancer Res; 1984 Jul; 44(7):2971-5. PubMed ID: 6539166
[TBL] [Abstract][Full Text] [Related]
24. Human primary colon carcinomas xenografted into nude mice. I. Characterization of plasminogen activators expressed by primary tumors and their xenografts.
Cajot JF; Sordat B; Kruithof EK; Bachmann F
J Natl Cancer Inst; 1986 Sep; 77(3):703-12. PubMed ID: 3091899
[TBL] [Abstract][Full Text] [Related]
25. Localization and immunological characterization of plasminogen activators in human prostate tissue.
Kirchheimer J; Binder BR
Haemostasis; 1983; 13(6):358-62. PubMed ID: 6199265
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen activator in human tears.
Stevens JD; Marshall JM; Benjamin L; Cederholm-Williams SA; Bron AJ
Eye (Lond); 1992; 6 ( Pt 6)():653-8. PubMed ID: 1289146
[TBL] [Abstract][Full Text] [Related]
27. Plasminogen activators in alveolar bone in man.
Björlin G; Ljungnér H; Astedt B
Acta Odontol Scand; 1986 Jun; 44(3):173-5. PubMed ID: 3461663
[TBL] [Abstract][Full Text] [Related]
28. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.
Duffy MJ; O'Grady P; Devaney D; O'Siorain L; Fennelly JJ; Lijnen HJ
Cancer; 1988 Aug; 62(3):531-3. PubMed ID: 3134120
[TBL] [Abstract][Full Text] [Related]
29. Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity.
Camiolo SM; Markus G; Evers JL; Hobika GH; DePasquale JL; Beckley S; Grimaldi JP
Int J Cancer; 1981 Feb; 27(2):191-8. PubMed ID: 6169657
[TBL] [Abstract][Full Text] [Related]
30. Plasminogen activators in human gastric cancers: correlation with DNA ploidy and immunohistochemical staining.
Takai S; Yamamura M; Tanaka K; Kawanishi H; Tsuji M; Nakane Y; Hioki K; Yamamoto M
Int J Cancer; 1991 Apr; 48(1):20-7. PubMed ID: 1902201
[TBL] [Abstract][Full Text] [Related]
31. Plasma urokinase-type plasminogen activator correlates to bone scintigraphy in prostatic carcinoma.
Hienert G; Kirchheimer JC; Christ G; Pflüger H; Binder BR
Eur Urol; 1988; 15(3-4):256-8. PubMed ID: 3145889
[TBL] [Abstract][Full Text] [Related]
32. [The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Hata M
Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1558-65. PubMed ID: 2512407
[TBL] [Abstract][Full Text] [Related]
33. Human leucocyte urokinase inhibitor--purification, characterization and comparative studies against different plasminogen activators.
Kopitar M; Rozman B; Babnik J; Turk V; Mullins DE; Wun TC
Thromb Haemost; 1985 Dec; 54(4):750-5. PubMed ID: 3879018
[TBL] [Abstract][Full Text] [Related]
34. Heterogeneity in plasminogen activator (PA) levels in human prostate cancer cell lines: increased PA activity correlates with biologically aggressive behavior.
Keer HN; Gaylis FD; Kozlowski JM; Kwaan HC; Bauer KD; Sinha AA; Wilson MJ
Prostate; 1991; 18(3):201-14. PubMed ID: 1902292
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical localization of urokinase-type plasminogen activator in Sertoli cells and tissue-type plasminogen activator in spermatogenic cells in the rat seminiferous epithelium.
Vihko KK; Kristensen P; Danø K; Parvinen M
Dev Biol; 1988 Mar; 126(1):150-5. PubMed ID: 3125078
[TBL] [Abstract][Full Text] [Related]
36. Tissue plasminogen activator activity in prostatic cancer.
Köller A; Kirchheimer J; Pflüger H; Binder BR
Eur Urol; 1984; 10(6):389-94. PubMed ID: 6085049
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activators in endoscopic biopsies as indicators of gastrointestinal cancer: comparison with resection specimens.
de Bruin PA; Verspaget HW; Griffioen G; Verheijen JH; Dooijewaard G; Lamers CB
Br J Cancer; 1989 Sep; 60(3):397-400. PubMed ID: 2506920
[TBL] [Abstract][Full Text] [Related]
38. Plasminogen activators in human xenografted oro-pharyngeal squamous cell carcinomas.
Björlin G; Ljungnér H; Wennerberg J; Astedt B
Acta Otolaryngol; 1987; 104(5-6):568-72. PubMed ID: 3434279
[TBL] [Abstract][Full Text] [Related]
39. Urokinase- and tissue-type plasminogen activators in keratinocytes during wound reepithelialization in vivo.
Grøndahl-Hansen J; Lund LR; Ralfkiaer E; Ottevanger V; Danø K
J Invest Dermatol; 1988 Jun; 90(6):790-5. PubMed ID: 3131440
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical localization of urokinase- and tissue-type plasminogen activators in psoriatic skin.
Grøndahl-Hansen J; Ralfkiaer E; Nielsen LS; Kristensen P; Frentz G; Danø K
J Invest Dermatol; 1987 Jan; 88(1):28-32. PubMed ID: 3098860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]